Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AS2717638 is an orally active and selective lysophosphatidic acid receptor 5 (LPA5) antagonist (IC50: 38 nM for hLPA5). It also significantly improves PGF2α-, PGE2-, and AMPA-induced allodynia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 148.00 | |
5 mg | In stock | $ 322.00 | |
10 mg | In stock | $ 538.00 | |
25 mg | In stock | $ 869.00 | |
50 mg | In stock | $ 1,180.00 | |
100 mg | In stock | $ 1,590.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 353.00 |
Description | AS2717638 is an orally active and selective lysophosphatidic acid receptor 5 (LPA5) antagonist (IC50: 38 nM for hLPA5). It also significantly improves PGF2α-, PGE2-, and AMPA-induced allodynia. |
Targets&IC50 | hLPA5:38 nM |
Molecular Weight | 447.48 |
Formula | C25H25N3O5 |
CAS No. | 2148339-28-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 54mg/mL (120.7mM), sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AS2717638 2148339-28-8 Others AS-2717638 AS 2717638 inhibitor inhibit